JAELYN ANDERSON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BOURBONNAIS, IL NPI 1659909372

General Payments — all program years on this page

$1,465.37

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 70
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $480.22 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $468.6618
Education $11.561

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $52.971
2022 $314.9117
2023 $617.2733
2024 $480.2219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100267594 Novo Nordisk Inc $21.12 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100320192 Novo Nordisk Inc $19.06 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100345048 Novo Nordisk Inc $22.43 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100493409 Novo Nordisk Inc $16.29 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100499041 Novo Nordisk Inc $19.53 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104273229 AstraZeneca Pharmaceuticals LP $30.93 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104342624 AstraZeneca Pharmaceuticals LP $5.31 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104625466 AstraZeneca Pharmaceuticals LP $26.99 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104732061 AstraZeneca Pharmaceuticals LP $22.34 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105537054 AstraZeneca Pharmaceuticals LP $11.56 05/02/2024 Education Undisputed 01/23/2026 View at CMS
1105566736 AstraZeneca Pharmaceuticals LP $124.91 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105813789 AstraZeneca Pharmaceuticals LP $22.45 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105855324 AstraZeneca Pharmaceuticals LP $24.79 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105889725 AstraZeneca Pharmaceuticals LP $24.73 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116337157 GlaxoSmithKline, LLC. $15.39 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135686730 Lilly USA, LLC $20.28 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137584972 Almatica Pharma LLC $17.31 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153286222 Ultragenyx Pharmaceutical Inc. $19.93 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153507657 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.87 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.